{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:44:48Z","timestamp":1792118688386,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004681","name":"Higher Education Commission, Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.colsurfb.2020.111209","type":"journal-article","created":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T10:27:06Z","timestamp":1592735226000},"page":"111209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model"],"prefix":"10.1016","volume":"194","author":[{"given":"Isra","family":"Rana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Mohsin","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawad Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9537-4897","authenticated-orcid":false,"given":"Fakhar ud","family":"Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0915-3527","authenticated-orcid":false,"given":"Muhammad","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Salman","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Ik","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3753-034X","authenticated-orcid":false,"given":"Alam","family":"Zeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2020.111209_bib0005","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0010","series-title":"Depression Fact Sheet","author":"WHO","year":"2020"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12199-008-0073-6","article-title":"Molecular epidemiology of major depressive disorder","volume":"14","author":"Kiyohara","year":"2009","journal-title":"Environ. Health Prev. Med."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nyas.12738","article-title":"The interface of depression and cardiovascular disease: therapeutic implications","volume":"1345","author":"Seligman","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0025","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0030","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","article-title":"Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression","volume":"22","author":"Shirayama","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4088\/JCP.v63n0309","article-title":"Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial","volume":"63","author":"Goldstein","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0040","first-page":"153","article-title":"Duloxetine in the treatment of generalized anxiety disorder","volume":"2","author":"Wright","year":"2009","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0050","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0893-133X(00)00220-7","article-title":"Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects","volume":"24","author":"Turcotte","year":"2001","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/00912700022008810","article-title":"Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor","volume":"40","author":"Sharma","year":"2000","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0060","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/dmd.31.9.1142","article-title":"Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects","volume":"31","author":"Lantz","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood\u2013brain barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0070","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1476-5381.2011.01557.x","article-title":"Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings","volume":"165","author":"O\u2019Brien","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0075","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jiec.2011.11.121","article-title":"A new fluoride mediated synthesis of mesoporous silica and their usefulness in controlled delivery of duloxetine hydrochloride a serotonin re-uptake inhibitor","volume":"18","author":"Ganesh","year":"2012","journal-title":"J. Ind. Eng. Chem."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpsychires.2018.01.015","article-title":"Duloxetine loaded-microemulsion system to improve behavioral activities by upregulating serotonin and norepinephrine in brain for the treatment of depression","volume":"99","author":"Sindhu","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1208\/s12249-011-9727-6","article-title":"Duloxetine HCl lipid nanoparticles: preparation, characterization, and dosage form design","volume":"13","author":"Patel","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/10717544.2013.822945","article-title":"Intranasal infusion of nanostructured lipid carriers (NLC) containing CNS acting drug and estimation in brain and blood","volume":"20","author":"Alam","year":"2013","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2019.02.002","article-title":"Simvastatin-loaded solid lipid nanoparticles for enhanced anti-hyperlipidemic activity in hyperlipidemia animal model","volume":"560","author":"Rizvi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery \u2013 a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0105","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/IJN.S146315","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors","volume":"12","author":"Din","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0110","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0115","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/02652048.2017.1337247","article-title":"Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration","volume":"34","author":"Qureshi","year":"2017","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119033","article-title":"Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity","volume":"577","author":"Khan","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0125","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/jphp.12727","article-title":"High payload itraconazole-incorporated lipid nanoparticles with modulated release property for oral and parenteral administration","volume":"69","author":"Zeb","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0130","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00394-016-1373-z","article-title":"Fish oil supplementation attenuates neuroinflammation and alleviates depressive-like behavior in rats submitted to repeated lipopolysaccharide","volume":"57","author":"Dang","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pbb.2003.11.001","article-title":"Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats","volume":"77","author":"Rex","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0140","doi-asserted-by":"crossref","DOI":"10.3791\/3769-v","article-title":"The tail suspension test","author":"Can","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0145","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3389\/fnins.2018.00888","article-title":"Identification of proteins differentially expressed in the striatum by melatonin in a middle cerebral artery occlusion rat model-a proteomic and in silico approach","volume":"12","author":"Shah","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0150","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1081\/DIS-120021814","article-title":"Nanotemplate engineering of cell specific nanoparticles","volume":"24","author":"Mumper","year":"2003","journal-title":"J. Dispers. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0155","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jcis.2009.06.033","article-title":"Influence of hydrophilic surfactants on the properties of multiple W\/O\/W emulsions","volume":"338","author":"Schmidts","year":"2009","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0160","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.nano.2011.04.004","article-title":"Design and potential application of PEGylated gold nanoparticles with size-dependent permeation through brain microvasculature","volume":"7","author":"Etame","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0170","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10611860400015936","article-title":"Nanoparticle surface charges alter blood-brain barrier integrity and permeability","volume":"12","author":"Lockman","year":"2004","journal-title":"J. Drug Target."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0175","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1021\/la104262k","article-title":"Physicochemical characterization of nanotemplate engineered solid lipid nanoparticles","volume":"27","author":"Howard","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.colsurfa.2016.03.065","article-title":"Formation and stability of solid lipid nanoparticles fabricated using phase inversion temperature method","volume":"499","author":"Gao","year":"2016","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0185","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.colsurfb.2011.03.029","article-title":"Polymorphism, crystallinity and hydrophilic\u2013lipophilic balance of stearic acid and stearic acid\u2013capric\/caprylic triglyceride matrices for production of stable nanoparticles","volume":"86","author":"Severino","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/pharmaceutics11080397","article-title":"Short term stability testing of efavirenz-loaded solid lipid nanoparticle (SLN) and nanostructured lipid carrier (NLC) dispersions","volume":"11","author":"Makoni","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0195","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0378-5173(98)00092-1","article-title":"Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN\u2122) dispersions","volume":"168","author":"Freitas","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0200","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0142-9612(02)00578-1","article-title":"The production and characteristics of solid lipid nanoparticles (SLNs)","volume":"24","author":"Hou","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery \u2013 drug release and release mechanism","volume":"45","author":"zur M\u00fchlen","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0210","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejpb.2013.12.015","article-title":"Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism","volume":"87","author":"Ravi","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0215","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejpb.2016.09.008","article-title":"Enhanced acute anti-inflammatory effects of CORM-2-loaded nanoparticles via sustained carbon monoxide delivery","volume":"108","author":"Qureshi","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0220","first-page":"52587","article-title":"The forced swim test as a model of depressive-like behavior","author":"Yankelevitch-Yahav","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0225","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10571-007-9254-x","article-title":"BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake","volume":"28","author":"Mannari","year":"2008","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0006-3223(02)01456-7","article-title":"MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients","volume":"53","author":"Molnar","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0235","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-1781(02)00005-7","article-title":"Decreased serum brain-derived neurotrophic factor levels in major depressed patients","volume":"109","author":"Karege","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0240","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S1461145710000738","article-title":"Blood BDNF concentrations reflect brain-tissue BDNF levels across species","volume":"14","author":"Klein","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0245","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5498\/wjp.v6.i3.283","article-title":"Neuroinflammation and cytokine abnormality in major depression: Cause or consequence in that illness?","volume":"6","author":"Jeon","year":"2016","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0250","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1742-2094-9-212","article-title":"Neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation","volume":"9","author":"Wu","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0255","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12667","article-title":"Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FOXO3a regulation","author":"Ali","year":"2020","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0260","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/mp.2016.46","article-title":"Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition","volume":"21","author":"Wong","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0265","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0270","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","article-title":"Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression","volume":"139","author":"Liu","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0275","article-title":"Cyclooxygenase-2 signalling pathway in the cortex is involved in the pathophysiological mechanisms in the rat model of depression","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0280","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.neuropharm.2011.04.033","article-title":"Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells","volume":"61","author":"Liu","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0285","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.7150\/thno.21254","article-title":"Current strategies for brain drug delivery","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0290","article-title":"Neuroprotective effects of carnosine-loaded elastic liposomes in cerebral ischemia rat model","author":"Zeb","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.colsurfb.2020.111209_bib0295","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2147\/IJN.S57565","article-title":"Formulation and delivery of itraconazole to the brain using a nanolipid carrier system","volume":"9","author":"Lim","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.colsurfb.2020.111209_bib0300","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.addr.2007.04.011","article-title":"Solid lipid nanoparticles for targeted brain drug delivery","volume":"59","author":"Blasi","year":"2007","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776520305658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776520305658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:54:51Z","timestamp":1760525691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776520305658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":60,"alternative-id":["S0927776520305658"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111209","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111209"}}